MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202327037854 A) filed by Enanta Pharmaceuticals, Inc., Watertown, U.S.A., on June 1, 2023, for 'novel spiropyrrolidine derived antiviral agents.'
Inventor(s) include Wang, Guoqiang; Shen, Ruichao; Jun; He, Yong; Xing, Xuechao; Cao, Hui; Gao, Xuri; Peng, Xiaowen; Panarese, Joseph, D.; and Or, Yat, Sun.
The application for the patent was published on March 7, under issue no. 10/2025.
According to the abstract released by the Intellectual Property India: "The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof, which inhibit coronavirus replication activity. The invention further relates to pharmaceutica...